ArticleFrontiers in chemistry2026
Semi-analytical Galerkin modeling of glucose transport and reaction in glucose oxidase-immobilized SBA-15 mesoporous silica.
Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The immobilization of glucose oxidase (GOx) in ordered mesoporous silica can provide a stable and efficient platform for glucose sensing and biocatalytic applications. This work examines a reaction-diffusion model governing glucose transport and enzymatic conversion inside GOx-loaded SBA-15 structures, with attention to both rod-shaped and cuboid particle geometries. Three coupled phenomena are incorporated into the model: intraparticle Fickian diffusion, Michaelis-Menten kinetics modified by competitive inhibition, and the dynamic exchange between glucose within the pore and in the surrounding bulk solution. The governing system of nonlinear PDE and ODE is solved in two complementary ways: the Method of Lines (MOL) and the semi-analytical Galerkin modal method. There is a high level of concordance between the semi-analytical and numerical solutions in a wide range of combinations in enzyme loadings and pore geometries shown in simulation findings. Absolute and relative errors remain minimal, particularly under diffusion-limited conditions at high enzyme loadings. Model predictions are further validated against experimental bulk depletion data reported in the literature, with mean absolute percentage error below 1% across the examined time window. A sensitivity analysis was performed to identify that the competitive inhibition constant has a more significant impact on glucose conversion within the parameters examined compared to the effective diffusivity. The semi-analytical galerkin formulation reduces the spatial problem to a small set of modal coefficients rather than the tens-to-hundreds of nodes required by Method of Lines, yielding a compact representation well-suited for parametric and sensitivity studies without loss of accuracy in the regimes examined. The results demonstrate that the semi-analytical Galerkin modal method offers a reliable alternative to conventional numerical approaches, yielding practical design guidance for mesoporous glucose biosensors on particle geometry, enzyme loading, and inhibition mitigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.